Statistical modelling based on structured surveys of Australian native possum excreta harbouring Mycobacterium ulcerans predicts Buruli ulcer occurrence in humans

  1. Koen Vandelannoote  Is a corresponding author
  2. Andrew H Buultjens
  3. Jessica L Porter
  4. Anita Velink
  5. John R Wallace
  6. Kim R Blasdell
  7. Michael Dunn
  8. Victoria Boyd
  9. Janet AM Fyfe
  10. Ee Laine Tay
  11. Paul DR Johnson
  12. Saras M Windecker
  13. Nick Golding
  14. Timothy P Stinear  Is a corresponding author
  1. University of Melbourne, Australia
  2. Millersville University, United States
  3. CSIRO Health and Biosecurity, Australia
  4. Victorian Infectious Diseases Reference Laboratory, Australia
  5. Department of Healt, Australia
  6. Austin Health, Australia
  7. Curtin University, Australia

Abstract

Background: Buruli ulcer (BU) is a neglected tropical disease caused by infection of subcutaneous tissue with Mycobacterium ulcerans. BU is commonly reported across rural regions of Central and West Africa but has been increasing dramatically in temperate southeast Australia around the major metropolitan city of Melbourne, with most disease transmission occurring in the summer months. Previous research has shown that Australian native possums are reservoirs of M. ulcerans and that they shed the bacteria in their fecal material (excreta). Field surveys show that locales where possums harbor M. ulcerans overlap with human cases of BU, raising the possibility of using possum excreta surveys to predict the risk of disease occurrence in humans.

Methods: We thus established a highly structured 12-month possum excreta surveillance program across an area of 350 km2 in the Mornington Peninsula area 70 km south of Melbourne, Australia. The primary objective of our study was to assess using statistical modelling if M. ulcerans surveillance of possum excreta provided useful information for predicting future human BU case locations.

Results: Over two sampling campaigns in summer and winter, we collected 2282 possum excreta specimens of which 11% were PCR positive for M. ulcerans-specific DNA. Using the spatial scanning statistical tool SaTScan, we observed non-random, co-correlated clustering of both M. ulcerans positive possum excreta and human BU cases. We next trained a statistical model with the Mornington Peninsula excreta survey data to predict the future likelihood of human BU cases occurring in the region. By observing where human BU cases subsequently occurred, we show that the excreta model performance was superior to a null model trained using the previous year's human BU case incidence data (AUC 0.66 vs 0.55). We then used data unseen by the excreta-informed model from a new survey of 661 possum excreta specimens in Geelong, a geographically separate BU endemic area to the southwest of Melbourne, to prospectively predict the location of human BU cases in that region. As for the Mornington Peninsula, the excreta-based BU prediction model outperformed the null model (AUC 0.75 vs 0.50) and pinpointed specific locations in Geelong where interventions could be deployed to interrupt disease spread.

Conclusions: This study highlights the One Health nature of BU by confirming a quantitative relationship between possum excreta shedding of M. ulcerans and humans developing BU. The excreta survey-informed modeling we have described will be a powerful tool for efficient targeting of public health responses to stop BU.

Funding: This research was supported by the National Health and Medical Research Council of Australia and the Victorian Government Department of Health (GNT1152807 and GNT1196396).

Data availability

The computer code and source data used in this study are available here: https://github.com/abuultjens/Possum_scat_survey_predict_human_BU.

Article and author information

Author details

  1. Koen Vandelannoote

    Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
    For correspondence
    kvandelannoote@pasteur-kh.org
    Competing interests
    The authors declare that no competing interests exist.
  2. Andrew H Buultjens

    Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5984-1328
  3. Jessica L Porter

    Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Anita Velink

    Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. John R Wallace

    Department of Biology, Millersville University, Millersville, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Kim R Blasdell

    CSIRO Health and Biosecurity, Geelong, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Michael Dunn

    CSIRO Health and Biosecurity, Geelong, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. Victoria Boyd

    CSIRO Health and Biosecurity, Geelong, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Janet AM Fyfe

    Doherty Institute for Infection and Immunity, Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  10. Ee Laine Tay

    Health Protection branch, Department of Healt, Victoria, Australia
    Competing interests
    The authors declare that no competing interests exist.
  11. Paul DR Johnson

    North Eastern Public Health Unit, Austin Health, Heidelberg, Australia
    Competing interests
    The authors declare that no competing interests exist.
  12. Saras M Windecker

    School of Ecosystem and Forest Sciences, University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4870-8353
  13. Nick Golding

    Spatial Ecology and Epidemiology Group, Curtin University, Bentley, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8916-5570
  14. Timothy P Stinear

    Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
    For correspondence
    tstinear@unimelb.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0150-123X

Funding

National Health and Medical Research Council (GNT1152807)

  • Timothy P Stinear

National Health and Medical Research Council (GNT1196396)

  • Timothy P Stinear

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Ethical approval for the use in this study of de-identified human BU case location, aggregated at mesh block level, was obtained from the Victorian Government Department of Health Human Ethics Committee under HREC/54166/DHHS-2019-179235(v3), "Spatial risk map of Buruli ulcer infection in Victoria".

Copyright

© 2023, Vandelannoote et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,365
    views
  • 147
    downloads
  • 18
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Koen Vandelannoote
  2. Andrew H Buultjens
  3. Jessica L Porter
  4. Anita Velink
  5. John R Wallace
  6. Kim R Blasdell
  7. Michael Dunn
  8. Victoria Boyd
  9. Janet AM Fyfe
  10. Ee Laine Tay
  11. Paul DR Johnson
  12. Saras M Windecker
  13. Nick Golding
  14. Timothy P Stinear
(2023)
Statistical modelling based on structured surveys of Australian native possum excreta harbouring Mycobacterium ulcerans predicts Buruli ulcer occurrence in humans
eLife 12:e84983.
https://doi.org/10.7554/eLife.84983

Share this article

https://doi.org/10.7554/eLife.84983

Further reading

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Bo Zheng, Bronner P Gonçalves ... Caoyi Xue
    Research Article

    Background:

    In many settings, a large fraction of the population has both been vaccinated against and infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, quantifying the protection provided by post-infection vaccination has become critical for policy. We aimed to estimate the protective effect against SARS-CoV-2 reinfection of an additional vaccine dose after an initial Omicron variant infection.

    Methods:

    We report a retrospective, population-based cohort study performed in Shanghai, China, using electronic databases with information on SARS-CoV-2 infections and vaccination history. We compared reinfection incidence by post-infection vaccination status in individuals initially infected during the April–May 2022 Omicron variant surge in Shanghai and who had been vaccinated before that period. Cox models were fit to estimate adjusted hazard ratios (aHRs).

    Results:

    275,896 individuals were diagnosed with real-time polymerase chain reaction-confirmed SARS-CoV-2 infection in April–May 2022; 199,312/275,896 were included in analyses on the effect of a post-infection vaccine dose. Post-infection vaccination provided protection against reinfection (aHR 0.82; 95% confidence interval 0.79–0.85). For patients who had received one, two, or three vaccine doses before their first infection, hazard ratios for the post-infection vaccination effect were 0.84 (0.76–0.93), 0.87 (0.83–0.90), and 0.96 (0.74–1.23), respectively. Post-infection vaccination within 30 and 90 days before the second Omicron wave provided different degrees of protection (in aHR): 0.51 (0.44–0.58) and 0.67 (0.61–0.74), respectively. Moreover, for all vaccine types, but to different extents, a post-infection dose given to individuals who were fully vaccinated before first infection was protective.

    Conclusions:

    In previously vaccinated and infected individuals, an additional vaccine dose provided protection against Omicron variant reinfection. These observations will inform future policy decisions on COVID-19 vaccination in China and other countries.

    Funding:

    This study was funded the Key Discipline Program of Pudong New Area Health System (PWZxk2022-25), the Development and Application of Intelligent Epidemic Surveillance and AI Analysis System (21002411400), the Shanghai Public Health System Construction (GWVI-11.2-XD08), the Shanghai Health Commission Key Disciplines (GWVI-11.1-02), the Shanghai Health Commission Clinical Research Program (20214Y0020), the Shanghai Natural Science Foundation (22ZR1414600), and the Shanghai Young Health Talents Program (2022YQ076).

    1. Epidemiology and Global Health
    Marina Padilha, Victor Nahuel Keller ... Gilberto Kac
    Research Article Updated

    Background:

    The role of circulating metabolites on child development is understudied. We investigated associations between children’s serum metabolome and early childhood development (ECD).

    Methods:

    Untargeted metabolomics was performed on serum samples of 5004 children aged 6–59 months, a subset of participants from the Brazilian National Survey on Child Nutrition (ENANI-2019). ECD was assessed using the Survey of Well-being of Young Children’s milestones questionnaire. The graded response model was used to estimate developmental age. Developmental quotient (DQ) was calculated as the developmental age divided by chronological age. Partial least square regression selected metabolites with a variable importance projection ≥1. The interaction between significant metabolites and the child’s age was tested.

    Results:

    Twenty-eight top-ranked metabolites were included in linear regression models adjusted for the child’s nutritional status, diet quality, and infant age. Cresol sulfate (β=–0.07; adjusted-p <0.001), hippuric acid (β=–0.06; adjusted-p <0.001), phenylacetylglutamine (β=–0.06; adjusted-p <0.001), and trimethylamine-N-oxide (β=–0.05; adjusted-p=0.002) showed inverse associations with DQ. We observed opposite directions in the association of DQ for creatinine (for children aged –1 SD: β=–0.05; pP=0.01;+1 SD: β=0.05; p=0.02) and methylhistidine (–1 SD: β = - 0.04; p=0.04;+1 SD: β=0.04; p=0.03).

    Conclusions:

    Serum biomarkers, including dietary and microbial-derived metabolites involved in the gut-brain axis, may potentially be used to track children at risk for developmental delays.

    Funding:

    Supported by the Brazilian Ministry of Health and the Brazilian National Research Council.